No black box warning on record for Actidogesic
As of the latest FDA labeling reviewed, Actidogesic (DEXBROMPHENIRAMINE MALEATE, ACETAMINOPHEN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Actidogesic medicine page for the complete safety profile.